# Round 1 — clinical anaesthesia reviewer (AI agent, deep-planner), 2026-10-26

Verdict: major revision.

## Major
- M1 Primary estimand tested on a null association (OR_ref 0.94): equivalence says nothing
  about attenuation; it tests differential error only. Report OR_ref/OR_pipe with CIs in
  abstract and results; reframe; lead attenuation discussion with dose slope and <55 mmHg
  metrics; discuss why the canonical exposure was null (low-risk cohort, creatinine-only,
  adjustment for duration — show crude → adjusted, 65 vs 55 threshold, post-induction
  hypotension, baseline risk); justify the 0.80–1.25 margin.
- M2 Episode table / >20 mmHg rule not safe bedside or alarm guidance: look-ahead bias
  (duration known only after the episode ends); circularity risk (non-pulsatile rule fires on
  real low-flow states — PEA, vasoplegia, cardiac compression); trivial dips dominate
  specificity; PPV 0.46; asymmetric harm. Validate deep flagged episodes against independent
  signals (EtCO2, pleth, vasopressor response); real-time table or explicit retrospective-only
  framing; rule performance in nadir <55; rewrite clinician sentence; remove "automated
  systems should treat … as probable artefact".
- M3 Cuff mechanism inferred, not established (VitalDB has no cuff-site field). Alternatives:
  reverse causation (clinician presses NIBP when the line looks wrong), sampling/flushing at
  the same time, positioning. Define denominators (1.8% vs 4.6%; 8× vs 5×). Do not recommend
  suspending cuff cycling (cuff is a safety cross-check). Fig 1 panel 2 may be cuff occlusion,
  not sampling. Tests: per-patient bimodality, automatic vs manual readings, subtype at −16 s,
  side/position.
- M4 No human adjudication; AI rater cannot carry the reference standard. Rename
  "waveform-verified" → "waveform-screened"; levelling/zero-drift limitation.
- M5 AKI ascertainment and selection: creatinine testing differs by department (thoracic 96%
  vs gynae/urology 46% in the AKI set); haemodilution; creatinine-count adjustment is
  post-exposure; confounding by indication; state that the ROR cancels shared confounding.
- M6 Monitoring window may miss post-induction hypotension (line placed after induction);
  report time from anaesthesia start to monitoring start.
- M7 Title/abstract methods-first; give clinical headline and OR_ref.

## Minor (selected)
Resolution claim contradicts outcome result (restrict to prevalence/burden); R4/R5 do not model
human charting; AIMS storage claim needs citation; check whether Pasma "recommended" the
7-point median; transplant patients in descriptive cohort; negative-control mechanism wording;
terminology (stopcock turned off to patient, flush, levelling error, AUT not AUC, gloss guard);
per-IQR ORs for TWA; EPV; vasopressor sensitivity (exploratory); mortality uninformative;
AF n = 13; verify Folks is VitalDB; monitor model and NIBP detection; Fig 4 duplicates
Table 2; check 2026 references; bridging may erase true nadirs.

## Missing literature suggested
Sun 2015 Anesthesiology 123:515; Südfeld 2017 BJA 119:57; Kouz 2022 BJA 129:478 (AWAKE);
Marcucci 2023 Ann Intern Med 176:605 (POISE-3); Saugel 2020 Crit Care 24:172; Wesselink 2018
BJA 121:706; Bijker 2007 Anesthesiology 107:213; Futier 2017 JAMA 318:1346; Gardner 1981
Anesthesiology 54:227; Hatib 2018; Wijnberge 2020 JAMA (verify all before citing).
